Variant report
Variant | esv1002081 |
---|---|
Chromosome Location | chr2:98234099-98240902 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:98236811..98238337-chr2:98279045..98280683,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000228486 | chromatin interactions |
ENSG00000115073 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2969467 | chr2:98234102-98234103 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs4069466 | chr2:98234117-98234118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4069467 | chr2:98234161-98234162 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs4069468 | chr2:98234162-98234163 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs148431580 | chr2:98234176-98234177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs189718055 | chr2:98234192-98234193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556083474 | chr2:98234201-98234202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142585301 | chr2:98234203-98234204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs397843460 | chr2:98234219-98234220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs397843461 | chr2:98234220-98234221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs4069471 | chr2:98234236-98234237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541941956 | chr2:98234276-98234277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs2309149 | chr2:98234373-98234374 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs2309150 | chr2:98234397-98234398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2871134 | chr2:98234399-98234400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2309151 | chr2:98234422-98234423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572661497 | chr2:98234425-98234426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2309152 | chr2:98234434-98234435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370739130 | chr2:98234442-98234443 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2309153 | chr2:98234453-98234454 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564691333 | chr2:98234488-98234489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2309154 | chr2:98234508-98234509 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs543801643 | chr2:98234509-98234510 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs117617873 | chr2:98234526-98234527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs2309155 | chr2:98234529-98234530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs2309156 | chr2:98234530-98234531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2871135 | chr2:98234561-98234562 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs185489654 | chr2:98234605-98234606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190990522 | chr2:98234626-98234627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565799261 | chr2:98234645-98234646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183223836 | chr2:98234654-98234655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58821906 | chr2:98234687-98234688 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs2309157 | chr2:98234694-98234695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs2309158 | chr2:98234695-98234696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2309159 | chr2:98234698-98234699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2103205 | chr2:98234704-98234705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2103206 | chr2:98234705-98234706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2248545 | chr2:98234755-98234756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs2259943 | chr2:98234756-98234757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs55830308 | chr2:98234785-98234786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs547140790 | chr2:98234868-98234869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2692941 | chr2:98234890-98234891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2692942 | chr2:98234906-98234907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562480576 | chr2:98234922-98234923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187309461 | chr2:98234934-98234935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539710386 | chr2:98235007-98235008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs4069472 | chr2:98235020-98235021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs191707263 | chr2:98235060-98235061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2692943 | chr2:98235080-98235081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188178350 | chr2:98235082-98235083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 17483303 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21509527 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:98233400-98240400 | Weak transcription | Fetal Muscle Trunk | muscle |
2 | chr2:98234400-98234600 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr2:98234400-98234600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr2:98234600-98235400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr2:98234800-98235800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
6 | chr2:98235400-98236200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr2:98235800-98236000 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr2:98235800-98236400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
9 | chr2:98236000-98236200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr2:98236000-98236200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
11 | chr2:98236000-98236400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr2:98236000-98236400 | Enhancers | Primary monocytes fromperipheralblood | blood |
13 | chr2:98236000-98236400 | Enhancers | Hela-S3 | cervix |
14 | chr2:98236000-98236400 | Enhancers | K562 | blood |
15 | chr2:98236200-98236400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr2:98236200-98240200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr2:98240200-98240800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
18 | chr2:98240400-98240600 | Enhancers | Fetal Muscle Trunk | muscle |
19 | chr2:98240600-98243400 | Weak transcription | Fetal Muscle Trunk | muscle |
20 | chr2:98240800-98242400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |